Support the news

Analyst Looks At Odds Of Biogen Takeover04:35
Download

Play
Biogen headquarters on Binney Street in Cambridge. (Jesse Costa/WBUR)
Biogen headquarters on Binney Street in Cambridge. (Jesse Costa/WBUR)
This article is more than 4 years old.

After a jump in its stock price of more than 9 percent on Tuesday, stock in Biogen, the Cambridge-based biotech giant, fell nearly 3 percent in trading on Wednesday.

The roller coaster follows a Wall Street Journal report this week that Biogen could be a takeover target. Biogen leadership is not commenting.

Peter Cohan, visiting lecturer on strategy and entrepreneurship at Babson College, joined Morning Edition to discuss

This segment aired on August 4, 2016.

Bob Oakes Twitter Host, Morning Edition
Bob Oakes has been WBUR's Morning Edition anchor since 1992.

More…

Support the news